Labor analgesia for the drug abusing parturient: Is there cause for concern?

Obstetrical and Gynecological Survey

Volumn 58, Issue 9, 2003, Pages 599-608

  Kuczkowski, Krzysztof M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMFEBUTAMONE; AMPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; COCAINE; GLYCERYL TRINITRATE; HALOTHANE; HYDRALAZINE; ILLICIT DRUG; ISOFLURANE; KETAMINE; LABETALOL; NICOTINE; OPIATE; PROPRANOLOL; SOLVENT; SUXAMETHONIUM;

ALCOHOLISM; ANALGESIA; BEHAVIOR THERAPY; CLINICAL FEATURE; COCAINE DEPENDENCE; CORONARY ARTERY CONSTRICTION; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; FETUS DISTRESS; HUMAN; HYPERTENSION; LABOR; NICOTINE REPLACEMENT THERAPY; OBSTETRIC ANALGESIA; OPIATE ADDICTION; PATIENT CARE; PREVALENCE; REVIEW; SOLUTIO PLACENTAE; SUBSTANCE ABUSE; THORAX PAIN; TOBACCO DEPENDENCE; UTERUS RUPTURE; WITHDRAWAL SYNDROME;

ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; ANALGESIA, OBSTETRICAL; ANESTHESIA, OBSTETRICAL; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; LABOR, OBSTETRIC; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 0041837181     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OGX.0000082148.97981.30     Document Type: Review

References (133)

1. Slutsker L, Smith R, Higginson G, et al. Recognizing illicit drug use in pregnant women: Reports from Oregon birth attendants. Am J Public Health 1993;83:61-64.
2. Parliamentary Office of Science and Technology. Common Illegal Drugs and Their Effects - Cannabis, Ecstasy, Amphetamines and LSD. London, England, House of Commons, 1996.
3. Bendersky M, Alessandri S, Gilbert p, et al. Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse 1996;22:349-362.
4. Davis RB. Drug and alcohol use in the former Soviet Union: Selected factors and future considerations. Int J Addictions 1994;29:303-305.
5. Smith BJ, Boer K, van Huis AM, et al. Cocaine use in pregnancy in Amsterdam. Acta Pediatr 1994;404:32-35.
6. Offidani C, Pomini F, Caruso A, et al. Cocaine during pregnancy: A critical review of the literature. Minerva Ginecol 1995;47:381-390.
7. Martinez Crespo JM, Antoiin E, Comas C, et al. The prevalence of cocaine abuse during pregnancy in Barcelona. Eur J Obstet Gynecol Reprod Biol 1994;56:165-167.
8. Hughes SC. Editorial AIDS: The focus turns to women. Int J Obstet Anesth 199;2:1-2.
9. th ed. McGraw-Hill, New York, 1994:1566-1617.
10. Matera C, Warren WB, Moomjy M, et al. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 1990;63:797-801.
11. Knisely IS, Spear ER, Green DI, et al. Substance abuse patterns in pregnant women. NIDA Res Monogr 1991;108:280-281.
12. Spence MR, Williams R, DiGregorio GI, et al. The relationship between recent cocaine use and pregnancy outcome. Obstet Gynecol 1991;78:326-329.
13. McCalla S, Minkoff HL, Feldman J, et al. Predictors of cocaine use in pregnancy, Obstet Gynecol 1992;79:641-644.
14. Flemingg JA, Byck R, Barash PG. Pharmacology and therapeutic applications of cocaine. Anesthesiology 1990;73:518-531.
15. Hatsakami DK, Fischman MW. Crack cocaine and cocaine hydrochloride: Are the differences myth or reality? JAMA 1996;276:1580-1588.
16. Fred S. On the general effects of cocaine (1885). Drug Depend 1970;5:15-17.
17. Gold MS, Washton AM, Dackis CA. Cocaine abuse: Neurochemistry, phenomenology and treatment. NIDA Res Monogr 1985;61:130-150.
18. Pitts DK, Marwah J. Anatomic actions of cocaine. Can J Physiol Pharmacol 1989;67:1168-1176.
19. Spraure ME. Substance abuse and HIV in pregnancy. Clin Obstet Gynecol 1996;39:316-332.
20. Kuczkowski KM. Anesthetic Implications of Drug Abuse in Pregnancy. J Clin Anesth 2003 (in press).
21. Kloner RA, Hale S, Alker K, et al. The effects of acute and chronic cocaine use on the heart. Circulation 1992;85:407-419.
22. Woods Jr JR, Plessinger MA. Pregnancy increases cardiovascular toxicity of cocaine. Am J Obstet Gynecol 1990;162:529-534.
23. Chao CR. Cardiovascular effects of cocaine during pregnancy. Semin Perinatol 1996;20:107-114.
24. Liu SS, Forester RM, Murphy GS, et al. Anaesthesia management of a parturient with myocardial infarction related to cocaine use. Can J Anaesth 1992;39:858-861.
25. Billman GE. Mechanisms responsible for the cardiotoxic effects of cocaine. FASEB 1990;14:2469-2475.
26. Nochas GG, Trouve R, Manger WM. Cocaine, catecholamines and cardiac toxicity. Acta Anaesthesiol Scand 1990;34:77-81.
27. Franker TD, Temesy-Amos PN, Brewster PS, et al. Mechanism of cocaine-induced myocardial depression in dogs. Circulation 1990;81:1012-1016.
28. Rodriquez EM, Mofenson LM, Chang BH, et al, Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission, AIDS 1996;10:273-282.
29. King JC. Substance abuse in pregnancy: Symposium on women's healthcare. Subst Abuse in Pregnancy 1997;102:135-150.
30. Towers CV, Pircon RA, Nageotte MP, et al. Cocaine intoxication presenting as preclampsia and eclampsia, Obstet Gynecol 1993;81:545-547.
31. Kain ZN, Mayes LC, Ferris CA, et al. Cocaine abusing parturients undergoing cesarean section: A cohort study. Anesthesiology 1996;85:1028-1035.
32. Birnbach DJ, Stein DJ, Grunebaum A, et al. Cocaine screening of parturients without prenatal care: An evaluation of a rapid screening assay. Anesth Analg 1997;84:76-79.
33. Oyler J, Darwin WD, Preston KL, et al. Cocaine disposition in the meconium from newborns of cocaine-abusing mothers and urine of adult drug users. J Analyt Toxicol 1996;20:453-462.
34. Kline J, Ng SK, Schittini M, et al. Cocaine use during pregnancy: Sensitive detection by hair assay. Am J Publ Health 1997;87:352-358.
35. Grant T, Brown Z, Callahan C, et al. Cocaine exposure during pregnancy: Improving assessment with radioimmunoassay of maternal hair. Obstet Gynecol 1994;83:524-531.
36. Krishna RB, Levitz M, Dancis J. Transfer of cocaine by the perfused human placenta: The effect of binding to serum proteins. Am J Obstet Gynecol 1993;169:1418-1423.
37. Plessinger MA, Woods JR Jr. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol 1993;36:267-278.
38. Moore TR, Sorg J, Miller L, et al. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol 1986;155:883-888.
39. Dombrowski MP, Wolfe HM, Welsh RA, et al. cocaine abuse is associated with abruptio placentae and decreased birth weight but not shorter labor. Obstet Gynecol 77:130-141, 1991.
40. McGregor SN, Keith LG, Chasnoff IJ. Cocaine use during pregnancy: Adverse perinatal outcome. Am J Obstet Gyncol 1987;157:686-690.
41. Mishra A, Landzberg BR, Parente IT. Uterine rupture in association with alkaloidal cocaine use. Am J Obstet Gynecol 1995;173:243-244.
42. Buehler BA. Cocaine. How dangerous is it during pregnancy? Nebr Med J 1995;80:116-117.
43. Iriye BK, Bristow RE, Hsu CD, et al. Uterine rupture associated with recent antepartum cocaine abuse. Obstet Gynecol 1994;83:840-841.
44. Lampley EC, Williams S, Myers SA. Cocaine-associated rhabdomyolysis causing renal failure in pregnancy. Obstet Gynecol 1996;87:804-806.
45. Moen MD, Caliendo MJ, Marshall W, et al. Hepatic rupture in pregnancy associated with cocaine use. Obstet Gynecol 1993;82:687-689.
46. Center for Disease Control. Urogenital anomalies in the offspring of women using cocaine during early pregnancy. MMWR Morb Mortal Wkly Rep 1989;38:536-542.
47. Birnbach DJ, Stein DJ, Thomas K, et al. Cocaine abuse in the parturient: What are the anesthetic implications? Anesthesiology 1993;79:A988 (abstr).
48. Birnbach DJ, Stein DJ, Grunebaum A, et al. Detection of multiple drug use in high risk patients using a new screening assay. Anesthesiology 1997;87:A892 (abstr).
49. Kreek MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis 1996;15:73-96.
50. Vertommen ID, Hughes SC, Rosen MA, et al. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. Anesthesiology 1992;76:1580-1587.
51. Hughes SC, Vertommen JD, Rosen MA, et al. Cocaine induced hypertension in the ewe and response to treatment with labetalol. Anesthesiology 1991;77:A1075 (abstr).
52. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995;333:1267-1271.
53. Derlet RW, Tseng CC, Albertson TE. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats. J Emerg Med 1994;12:1-4.
54. Birnbach DJ. Cardiovascular disease in the pregnant patient: A new risk factor. Cardiovasc Risk Fact 1994;4:28-33.
55. Boylan JF, Cheng DC Sandler AN, et al. Cocaine toxicity and isoflurane anesthesia: Hemodynamic, myocardial, metabolism, and regional blood flow effects in swine. J Cardiothorac Vasc Anesth 1996;10:772-777.
56. Murphy JL. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse. Can J Anesth 1993;40:160-164.
57. Jatlow P, Barsh PG, van Dyke C, et al. Cocaine succinylcholine sensitivity: A new caution. Anesth Analg 1979;58:235-238.
58. Hollander JE, Hoffman RS, Gennis P, et al. Nitroglycerine in the treatment of cocaine associated chest pain-clinical safety and efficacy. J Toxicol Clin Toxicol 1994;32:243-256.
59. Fox BS. Development of a therapeutic vaccine for the treatment of cocaine addiction. Drug Alcohol Depend 1997;48:153-158.
60. Fox BS, Kantak KM, Edwards MA, et al. Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Med 1996;2:1129-1132.
61. Bagasra O, Forman LJ, Howeedy A, et al. A potential vaccine for cocaine abuse prophylaxis. Immunopharmacology 1992;23:173-179.
62. Henry JA. Ecstasy and the dance with death. Br Med J 1992;305:775.
63. Ong BH. Hazards to health: Dextroamphetamine poisoning. N Engl J Med 1962;266:1321-1322.
64. Elliot RH, Rees GB. Amphetamine ingestion presenting as eclampsia. Can J Anaesth 1990;37:130-133.
65. Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: Four cases. J Emerg Med 1999;17:469-471.
66. Stewart JL, Mecker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 1997;21:515-517.
67. King JC. Substance abuse in pregnancy: A bigger problem than you think. Postgrad Med 1997;102:135-150.
68. Henry JA, Jeffreys KJ, Dawlings S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (ecstasy). Lancet 1992;340:384-387.
69. Plessinger MA. Prenatal exposure to amphetamines: Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998;25:119-138.
70. Eriksson M, Larson G, Winbladh B, et al. The influence of amphetamine addiction on pregnancy and the newborn infant. Acta Paediatr Scand 1978;67:95-99.
71. Levin JN. Amphetamine ingestion with biliary atresia. Pediatrics 1971;79:130-131.
72. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971;1:523-527.
73. Wagner CL, Katikaneni LD, Cox TH, et al. The impact of prenatal drug exposure on the neonate. Obstet Gynecol Clinic North Am 1998;25:169-194.
74. Michel R, Adams AP. Acute amphetamine abuse: Problems during general anesthesia for neurosurgery. Anaesthesia 1979;34:1016-1019.
75. Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology 1972;36:357-363.
76. Samuels SI, Maze A, Albright A. Cardiac arrest in a chronic amphetamine abuser. Anesth Analg 1979;58:528-530.
77. Little BB, Snell LM, Klein YR, et al. Maternal and fetal effects of heroin addiction during pregnancy. J Reprod Med 1990;35:159-165.
78. Hoegerman G, Schnoll S. Narcotic use in pregnancy. Clin Perinatol 1991;18:51-76.
79. Rodnquez EM, Mofenson LM, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996;10:273-282.
80. Kliman L. Drug dependence and pregnancy: Antenatal and intrapartum problems. Anaesth Intensive Care 1990;18:358-360.
81. Stoelting RK. Opioid agonists and antagonists. In Stoelting RK, editor. Pharmacology and Physiology in Anesthesia Practice. Philadelphia. PA, Lippincott. 1987:77-112.
82. Weintraub SJ, Naulty JS. Acute abstinence syndrome after epidural injection of butorphanol. Anesth Analg 1985;64:452-453.
83. Naeye RL, Blanc W, LeBlanc W, et al. Fetal complications of maternal heroin addiction: Abnormal growth, infections and episodes of stress. J Pediatr 1973;83:1055-1061.
84. Bell GL, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995;42:261-275.
85. Gold MS, Pottash AL, Extein I, et al. Clonidine in acute opiate withdrawal. N Engl J Med 1980;302:1421-1422.
86. Wood PR, Soni N. Anesthesia and substance abuse. Anaesthesia 1989;44:672-680.
87. Koppel BS, Tuchman AJ, Mangiardi JR, et al. Epidural spinal infection in intravenous drug abusers. Arch Neurol 1988;45:1331-1337.
88. Hughes SC, Dailey PA, Landers D, et al. Parturients infected with human immunodeficiency virus and regional anesthesia: Clinical and immunologic response. Anesthesiology 1995;82:32-37.
89. Resnick L, Berger JR, Shapshak P, et al. Early penetration of blood-brain barrier by HIV. Neurology 1988;38:9-14.
90. Kazner MD. Neuropathology of AIDS. Crit Rev Neurobiol 1990;5:313-362.
91. National Institute of Drug Abuse. National Household Survey of Drug Abuse: Population Estimates 1997. Washington, DC, Government Printing Office, 1998.
92. Press A, Done AK. Solvent sniffing: Physiological effects and community control measures. Pediatrics 1967;39:451-461.
93. Sasa M, Igarashi S, Miyazaki T, et al. Equilibrium disorders with diffuse brain atrophy in long-tern toluene sniffing. Arch Otorhinolaryngol 1978;221:163-169.
94. Grabski DG. Toluene sniffing produces cerebellar degeneration. Am J Psychiatry 1961;118:461-462.
95. Murata K, Araki S, Yokoyama K, et al. Changes in autonomic function as determined by ECG P-R interval variability in sandal, shoe and leather workers exposed to n-hexane, xylene and toluene. Neurotoxicology 1994;15:867-875.
96. Cunningham SR, Dalzell GWN, McGirr P, et al. Myocardial infarction and primary ventricular fibrillation after glue sniffing. Br Med 1987;294:739-740.
97. Reyes de la Rocha S, Brown MA, Fortnberry JD. Pulmonary function abnormalities in intentional spray paint inhalation. Chest 1987;92:100-104.
98. Carliste EJ, Donnelly SM, Vasuvattakul S, et al. Glue sniffing and distal renal tubular acidosis: Sticking to the facts. J Am Soc Nephrol 1991;1:1019-1027.
99. Wilkins-Haug L, Gabow PA. Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes. Obstet Gynecol 1991;77:504-509.
100. Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am 1998;25:153-167.
101. Hersh JH. Toluene embryopathy: Two new cases. J Med Genet 1989;26:333-337.
102. Hersh JH, Podruch PE, Rogers G, et al. Toluene embryopathy. J Pediatr 1985;106:922-927.
103. Sasa M, Igarashi S, Miyazaki T, et at. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing. Arch Otorhinolaryngol 1978;221:163-169.
104. Eriksson KM, Haug K, Salesmen KA, et al. Smoking habits among pregnant women in Norway 1994-1995. Acta Obstet Gynecol Scand 1998:77:159-164.
105. National Institute on Drug Abuse. National Household Survey of Drug Abuse: Population Estimates 1990 (Publication no. 91-1732). Rockville, MD, Department of Health and Human services, 1991.
106. Sprauve ME. Substance abuse and HIV in pregnancy. Clin Obstet Gynecol 1996;39:316-332.
107. Prager K, Malin H, Spiegler D, et al. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants. Pub Health Rep 1984;99:117-127.
108. Lackmann GM, Salzberger U, Tollner U, et al. Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst 1999;91:459-465.
109. Economides D, Braithwaite I. Smoking, pregnancy, and the fetus. J Royal Soc Health 1994;114:198-201.
110. Rodkey FL, O'Neal JD, Collison HA. Oxygen and carbon monoxide equilibria of human adult hemoglobin at atmospheric and elevated pressure. Blood 1969;33:57-65.
111. Feng T. Substance abuse in pregnancy. Curr Opin Obstet Gynecol 1993;5:16-23.
112. Kistin N, Handler A, Davis F, et al. Cocaine and cigarettes: A comparison of risks. Paediatr Perinatal Epidemiol 1996;10:269-278.
113. Surgeon General. The health consequences of smoking for women: A report of the Surgeon General 1983. Washington, DC; US Government Printing Office; 1983; p. 191-249.
114. Castles A, Adams EK, Melvin CL, et al. Effects of smoking during pregnancy. Am J Prev Med 1999;16:208-215.
115. Luciano A, Bolognani M, Biondani P, et al. The influence of maternal passive and light active smoking on intrauterine growth and body composition of the newborn. Eur J Clin Nutr 1998;52:760-763.
116. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: A light and electron microscopic study. Placenta 1982;3:243-256.
117. Cnattingius S, Forman MR, Berendes HM, et al. Effect of age, parity and smoking on pregnancy outcome: A population based study. Am J Obstet Gynecol 1993;168:16-21.
118. MacDorman MF, Cnatlnglus S, Hoffman HJ, et al. Sudden infant death syndrome and smoking in the United States and Sweden. Am J Epidemiol 1997;146:249-257.
119. Najman JM, Lanyon A, Andersen M, et al. Socioeconomic status and maternal cigarette smoking before, during and after a pregnancy. Aust N Z J Publ Health 1998;22:60-66.
120. American College of Obstetricians and Gynecologists. Smoking and Reproductive Health (ACOG Technical Bulletin No. 180). Washington, DC, ACOG, 1993.
121. Berovitz NL. Nicotine replacement therapy during pregnancy JAMA 1991;266:3174-3177.
122. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999;28:72-76.
123. Ferry LH, Bruchette M. Efficacy of bupropion for smoking cessation in nondepressed smokers. J Addict Dis 1994;13:249.
124. Jorenby DF, Leischov SI, Nides MA, et at. A controlled trial of sustained release bupropion and nicotine patch or both for smoking cessation, N Engl J Med 1999;340:685-691.
125. Pearce AC, Jones RM. Smoking and anesthesia: Preoperative abstinence and perioperative morbidity. Anesthesiology 1984;61:576-584.
126. Ebrahim SH, Luman ET, Floyd RL, et al. Alcohol consumption by pregnant women in the United States during 1988-1995;Obstet Gynecol 1998;92:187-192.
127. Lemoine P, Harroussean H, Borteyrn JP. Les enfants de parents alcolques: Anomalies observees - A propos de 127 cases. Ouest Med 1968;25:477-482.
128. Pietrantoni M, Knuppel RA. Alcohol use in pregnancy. Clin Perinatol 1991;18:93-111.
129. Council on Scientific Affairs, American Medical Association. Fetal effects of maternal alcohol abuse. JAMA 1983;249:2517-2521.
130. Pinazo-Duran MD, Renau-Piqueras J, Guem C, et al. Optic nerve hypoplasia in fetal alcohol syndrome: An update. Eur J Opththalmol 1997;7:262-270.
131. Guerri C, Renau-Piqueras J. Alcohol, astroglia and brain development. Mol Neurobiol 1997;15:65-81.
132. Beattie MC, Longabaugh R, Elliott G, et al. Effect of the social environment on alcohol involvement and subjective well-being prior to alcohol treatment. J Stud Alcohol 1993;54:283-296.
133. Sverdlov BN, Holley FO, Maitre PI. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics. Anesthesiology 1990;72:455-461.